#United States #New York #Advancium Health Network #CobiCure #Michele Cleary

Advancium Health Network Elevates Michele Cleary to CEO

In a significant leadership move, Advancium Health Network has announced the appointment of Dr. Michele Cleary as its new Chief Executive Officer. This decision comes at a pivotal time as the organization seeks to accelerate its innovative initiatives in pediatric healthcare. With over 20 years of experience in scientific innovation and drug development, Dr. Cleary is set to propel the organization into its next phase while fostering collaborations aimed at enhancing patient outcomes.

Previously holding the position of President and Chief Scientific Officer at Advancium, Dr. Cleary is recognized for her transformative contributions to pediatric drug development. Ron Mitchell, a member of the Board of Directors and Managing Partner at Low Post Ventures, highlighted her remarkable capacity to deliver results and her dedication to improving the lives of families in need. Under her guidance, Advancium has established valuable partnerships, strategically identified a robust pipeline of impactful programs, and redefined conventional timelines associated with drug development.

Dr. Cleary's depth of expertise encompasses a broad spectrum of areas including translational research, clinical strategies, and FDA engagement. Her extensive background prior to joining Advancium includes senior roles at notable pharmaceutical companies like Bristol Myers Squibb and Merck Research Laboratories, where she honed her leadership skills and fostered significant academic partnerships. She also played a crucial role as the first CEO of the Mark Foundation for Cancer Research, showcasing her commitment to improving healthcare innovation.

Her recent appointment has been met with optimism from key affiliates, including Jim Flynn from Deerfield Management, who remarked on her unwavering commitment to improving outcomes for children with rare diseases. Flynn emphasized that her leadership will be vital for Advancium and its nonprofit subsidiary, CobiCure, as they work toward substantial advancements in healthcare for those most affected.

Dr. Cleary expressed her honor and excitement in leading Advancium into this new chapter. “Together with our exceptional team and partners, we are redefining what's possible for children with rare diseases. These families cannot wait, and neither will we,” she stated. Her vision focuses on accelerating progress by expanding the portfolio of medical devices and therapies, deepening collaborations with leading research institutions, and scaling innovative funding models aimed at addressing the needs of historically underserved pediatric populations.

Advancium Health Network operates with a mission-driven philosophy, aiming to innovate healthcare approaches through a unique integration of for-profit infrastructure and nonprofit ideals. The organization strives to leverage its partnerships and resources to tackle some of the most pressing healthcare challenges faced by children dealing with rare diseases.

CobiCure, a crucial component of Advancium's mission, is dedicated to closing critical gaps in pediatric healthcare. By prioritizing the development of cutting-edge medical devices and treatments for childhood diseases, CobiCure moves beyond conventional profit-driven methods to ensure that life-saving solutions reach the patients who need them desperately. Their collaboration with Deerfield Management provides access to a vast healthcare and life sciences innovation ecosystem, further enhancing their capacity to make impactful contributions in pediatric medicine.

With Dr. Michele Cleary at the helm, both Advancium Health Network and CobiCure are well-positioned to make meaningful strides in pediatric healthcare, ultimately changing the lives of children and families struggling with rare diseases. As they continue to forge strong partnerships and innovate solutions, the hope for a better future in pediatric health intensifies, signaling a new era of possibilities for the next generation.

About Advancium Health Network

Advancium Health Network is a pioneering public charity focused on removing barriers in healthcare. Combining innovative business practices with charitable ideals, Advancium collaborates with diverse industry partners to develop medical solutions that address the urgent needs of pediatric patients. For more information, visit Advancium Health.

About CobiCure

CobiCure, a nonprofit organization under Advancium Health Network, aims to accelerate the development of groundbreaking treatments and medical devices for childhood diseases. Leveraging a powerful network of partners, CobiCure prioritizes solutions that save lives over traditional profit motives. Learn more at CobiCure.